Evidence map›Paper›PMID 33348086›Full record

ArticleOphthalmology. Retina2021

Local Anatomic Precursors to New-Onset Geographic Atrophy in Age-Related Macular Degeneration as Defined on OCT.

Malini Veerappan Pasricha, Vincent Tai, Karim Sleiman, Katrina Winter, Stephanie J Chiu, Sina Farsiu, Sandra S Stinnett, Eleonora M Lad, Wai T Wong, Emily Y Chew and 2 more

Open access · greenAbstract read
In one paragraph

Article in Ophthalmology. Retina, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 20 citations in OpenAlex.

  1. Trial
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Malini Veerappan PasrichaDuke Eye Center, Duke University Medical Center, Durham, North Carolina; Byers Eye Institute, Stanford University Medical Center, Palo Alto, California.
Vincent TaiDuke Eye Center, Duke University Medical Center, Durham, North Carolina.
Karim SleimanDuke Eye Center, Duke University Medical Center, Durham, North Carolina; The Statistical Consulting Center, Maa Data Group, Beirut, Lebanon.
Katrina WinterDuke Eye Center, Duke University Medical Center, Durham, North Carolina.
Stephanie J ChiuDuke Eye Center, Duke University Medical Center, Durham, North Carolina.
Sina FarsiuDuke Eye Center, Duke University Medical Center, Durham, North Carolina; Department of Biomedical Engineering, The Pratt School of Engineering, Duke University, Durham, North Carolina.
Sandra S StinnettDuke Eye Center, Duke University Medical Center, Durham, North Carolina.
Eleonora M LadDuke Eye Center, Duke University Medical Center, Durham, North Carolina.
Wai T WongNational Eye Institute, National Institutes of Health, Bethesda, Maryland.
Emily Y ChewNational Eye Institute, National Institutes of Health, Bethesda, Maryland.
Cynthia A TothDuke Eye Center, Duke University Medical Center, Durham, North Carolina; Department of Biomedical Engineering, The Pratt School of Engineering, Duke University, Durham, North Carolina. Electronic address: cynthia.toth@duke.edu.
Age-Related Eye Disease Study 2 Ancillary Spectral-Domain Optical Coherence Tomography Study Group
Duke Medical Center · USDuke University · USNational Institutes of Health · US

Funding

VISION RESEARCHP30EY005722 · NEI · DUKE UNIVERSITY · PI Vadim Y Arshavsky · 1985 to 2026
$19.3M
The Age-Related Eye Disease Study 2 (AREDS2)ZIAEY000485 · NEI · NATIONAL EYE INSTITUTE · PI CHEW, EMILY Y · 2009 to 2015
$990k
Age-Related Eye Disease Follow-up Study (AREDS) Follow-up StudyZIAEY000489 · NEI · NATIONAL EYE INSTITUTE · PI CHEW, EMILY Y · 2009 to 2025
$639k
Intramural NIH HHS ZIA EY000485NEI NIH HHS P30 EY005722
6 · The paper itself

Abstract

purposeIn macula-wide analyses, spectral-domain (SD) optical coherence tomography (OCT) features including drusen volume, hyperreflective foci, and OCT-reflective drusen substructures independently predict geographic atrophy (GA) onset secondary to age-related macular degeneration (AMD). We sought to identify SD OCT features in the location of new GA before its onset.

designRetrospective study.

participantsAge-Related Eye Disease Study 2 Ancillary SD OCT Study participants.

methodsWe analyzed longitudinally captured SD OCT images and color photographs from 488 eyes of 488 participants with intermediate AMD at baseline. Sixty-two eyes with sufficient image quality demonstrated new-onset GA on color photographs during study years 2 through 7. The area of new-onset GA and one size-matched control region in the same eye were segmented separately, and corresponding spatial volumes on registered SD OCT images at the GA incident year and at 2, 3, and 4 years previously were defined. Differences in SD OCT features between paired precursor regions were evaluated through matched-pairs analyses.

main outcome measuresLocalized SD OCT features 2 years before GA onset.

resultsCompared with paired control regions, GA precursor regions at 2, 3, and 4 years before (n = 54, 33, and 25, respectively) showed greater drusen volume (P = 0.01, P = 0.003, and P = 0.003, respectively). At 2 and 3 years before GA onset, they were associated with the presence of hypertransmission (P < 0.001 and P = 0.03, respectively), hyperreflective foci (P < 0.001 and P = 0.045, respectively), OCT-reflective drusen substructures (P = 0.004 and P = 0.03, respectively), and loss or disruption of the photoreceptor zone, ellipsoid zone, and retinal pigment epithelium (RPE, P < 0.001 and P = 0.005-0.045, respectively). At 4 years before GA onset, precursor regions were associated with photoreceptor zone thinning (P = 0.007) and interdigitation zone loss (P = 0.045).

conclusionsEvolution to GA is heralded by early local photoreceptor changes and drusen accumulation, detectable 4 years before GA onset. These precede other anatomic heralds such as RPE changes and drusen substructure emergence detectable 1 to 2 years before GA. This study thus identified earlier end points for GA as potential therapeutic targets in clinical trials.

Indexed as

AgedAged, 80 and overFemaleFollow-Up StudiesGeographic AtrophyHumansMacula LuteaMacular DegenerationMaleMiddle AgedProspective StudiesRetinal Pigment EpitheliumTime FactorsTomography, Optical CoherenceAge-Related Eye Disease Study 2Age-related macular degenerationGeographic atrophyLocalized precursorsSpectral-domain OCT

Identifiers

PMID33348086
PMCPMC8362836
OpenAlexW3116799886

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.